VOYA Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,403
Closed -$24K 2621
2019
Q1
$24K Hold
1,403
﹤0.01% 2539
2018
Q4
$19K Hold
1,403
﹤0.01% 2537
2018
Q3
$30K Hold
1,403
﹤0.01% 2575
2018
Q2
$60K Hold
1,403
﹤0.01% 2589
2018
Q1
$92K Hold
1,403
﹤0.01% 2481
2017
Q4
$102K Buy
1,403
+185
+15% +$15.3K ﹤0.01% 2499
2017
Q3
$112K Hold
1,218
﹤0.01% 2524
2017
Q2
$81K Buy
1,218
+179
+17% +$22.2K ﹤0.01% 2614
2017
Q1
$225K Buy
+1,039
New +$148K ﹤0.01% 2217
2016
Q1
Sell
-1,039
Closed -$340K 2531
2015
Q4
$340K Hold
1,039
﹤0.01% 1975
2015
Q3
$335K Sell
1,039
-220
-17% -$96.7K ﹤0.01% 1978
2015
Q2
$502K Sell
1,259
-73
-5% -$31K ﹤0.01% 1929
2015
Q1
$656K Sell
1,332
-131
-9% -$50.8K ﹤0.01% 1731
2014
Q4
$523K Hold
1,463
﹤0.01% 1899
2014
Q3
$282K Sell
1,463
-262
-15% -$57.6K ﹤0.01% 2302
2014
Q2
$412K Sell
1,725
-288
-14% -$58.6K ﹤0.01% 2127
2014
Q1
$514K Hold
2,013
﹤0.01% 1952
2013
Q4
$399K Hold
2,013
﹤0.01% 2127
2013
Q3
$340K Hold
2,013
﹤0.01% 2203
2013
Q2
$357K Buy
+2,013
New +$285K ﹤0.01% 2113

Other funds holding LUMO

VOYA Investment Management's LUMO Position: Q2 2019 in Review

VOYA Investment Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2019, closing a stake of 1,403 shares — an estimated $24K sold.

VOYA Investment Management first reported a position in LUMO in Q2 2013 and held it in 20 quarters. The position peaked at $656K in Q1 2015. 68 funds tracked by Wall St. Rank hold LUMO as of Q2 2019.

  • VOYA Investment Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • VOYA Investment Management sold 1,403 Lumos Pharma, Inc. Common Stock shares in Q2 2019, an estimated $24K.
  • VOYA Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 20 quarters.
  • VOYA Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $656K in Q1 2015.
  • 68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2019.

Based on VOYA Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.